Literature DB >> 32631183

Nonconsensual Dose Reduction Mandates are Not Justified Clinically or Ethically: An Analysis.

Stefan G Kertesz1, Ajay Manhapra1, Adam J Gordon1.   

Abstract

This manuscript describes the institutional and clinical considerations that apply to the question of whether to mandate opioid dose reduction in patients who have received opioids long-term. It describes how a calamitous rise in addiction and overdose involving opioids has both led to a clinical recalibration by healthcare providers, and to strong incentives favoring forcible opioid reduction by policy making agencies. Neither the 2016 Guideline issued by the Centers for Disease Control and Prevention nor clinical evidence can justify or promote such policies as safe or effective.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32631183      PMCID: PMC7938366          DOI: 10.1177/1073110520935337

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN: 1073-1105            Impact factor:   1.718


  45 in total

1.  Opioid Dependence vs Addiction: A Distinction Without a Difference?

Authors:  Jane C Ballantyne; Mark D Sullivan; Andrew Kolodny
Journal:  Arch Intern Med       Date:  2012-09-24

2.  Opioid Taper Is Associated with Subsequent Termination of Care: a Retrospective Cohort Study.

Authors:  Hector R Perez; Michele Buonora; Chinazo O Cunningham; Moonseong Heo; Joanna L Starrels
Journal:  J Gen Intern Med       Date:  2019-08-19       Impact factor: 5.128

3.  Yoga and Low Back Pain: No Fool's Tool.

Authors:  Douglas G Chang; Stefan G Kertesz
Journal:  Ann Intern Med       Date:  2017-06-20       Impact factor: 25.391

Review 4.  Depression in chronic pain: might opioids be responsible?

Authors:  Graham Mazereeuw; Mark D Sullivan; David N Juurlink
Journal:  Pain       Date:  2018-11       Impact factor: 6.961

5.  Addressing dual agency: getting specific about the expectations of professionalism.

Authors:  Jon C Tilburt
Journal:  Am J Bioeth       Date:  2014       Impact factor: 11.229

6.  Opioid medication discontinuation and risk of adverse opioid-related health care events.

Authors:  Tami L Mark; William Parish
Journal:  J Subst Abuse Treat       Date:  2019-05-05

7.  Underlying Factors in Drug Overdose Deaths.

Authors:  Deborah Dowell; Rita K Noonan; Debra Houry
Journal:  JAMA       Date:  2017-12-19       Impact factor: 56.272

8.  Distribution of Prescription Opioid Use Among Privately Insured Adults Without Cancer: United States, 2001 to 2013.

Authors:  Eric C Sun; Anupam B Jena
Journal:  Ann Intern Med       Date:  2017-09-12       Impact factor: 25.391

9.  Mortality After Discontinuation of Primary Care-Based Chronic Opioid Therapy for Pain: a Retrospective Cohort Study.

Authors:  Jocelyn R James; JoAnna M Scott; Jared W Klein; Sara Jackson; Christy McKinney; Matthew Novack; Lisa Chew; Joseph O Merrill
Journal:  J Gen Intern Med       Date:  2019-08-29       Impact factor: 5.128

View more
  2 in total

1.  The effect of state policies on rates of high-risk prescribing of an initial opioid analgesic.

Authors:  Bradley D Stein; Flora Sheng; Erin A Taylor; Andrew W Dick; Mark Sorbero; Rosalie Liccardo Pacula
Journal:  Drug Alcohol Depend       Date:  2021-12-28       Impact factor: 4.492

2.  Factors Associated with Pain Treatment Satisfaction Among Patients with Chronic Non-Cancer Pain and Substance Use.

Authors:  Leslie W Suen; Vanessa M McMahan; Christopher Rowe; Sumeet Bhardwaj; Kelly Knight; Margot B Kushel; Glenn-Milo Santos; Phillip Coffin
Journal:  J Am Board Fam Med       Date:  2021 Nov-Dec       Impact factor: 2.395

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.